{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:07:15Z","timestamp":1791140835812,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,26]],"date-time":"2011-11-26T00:00:00Z","timestamp":1322265600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Candida<\/jats:italic>-associated denture stomatitis is a frequent infectious disease. Treatment of this oral condition is difficult because failures and recurrences are common. The aim of this study was to test the in vitro antifungal activity of pure constituents of essentials oils.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Eight terpenic derivatives (carvacrol, farnesol, geraniol, linalool, menthol, menthone, terpinen-4-ol, and \u03b1-terpineol), a phenylpropanoid (eugenol), a phenethyl alcohol (tyrosol) and fluconazole were evaluated against 38 <jats:italic>Candida<\/jats:italic> isolated from denture-wearers and 10 collection <jats:italic>Candida<\/jats:italic> strains by the CLSI M27-A3 broth microdilution method.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Almost all the tested compounds showed antifungal activity with MIC ranges of 0.03-0.25% for eugenol and linalool, 0.03-0.12% for geraniol, 0.06-0.5% for menthol, \u03b1-terpineol and terpinen-4-ol, 0.03-0.5% for carvacrol, and 0.06-4% for menthone. These compounds, with the exception of farnesol, menthone and tyrosol, showed important in vitro activities against the fluconazole-resistant and susceptible-dose dependent <jats:italic>Candida<\/jats:italic> isolates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Carvacrol, eugenol, geraniol, linalool and terpinen-4-ol were very active in vitro against oral <jats:italic>Candida<\/jats:italic> isolates. Their fungistatic and fungicidal activities might convert them into promising alternatives for the topic treatment of oral candidiasis and denture stomatitis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6882-11-119","type":"journal-article","created":{"date-parts":[[2011,11,26]],"date-time":"2011-11-26T19:15:01Z","timestamp":1322334901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["In vitro activities of natural products against oral Candida isolates from denture wearers"],"prefix":"10.1186","volume":"11","author":[{"given":"Cristina","family":"Marcos-Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Eraso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucila","family":"Madariaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Quind\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,26]]},"reference":[{"key":"475_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1532-849X.2011.00698.x","volume":"20","author":"L Gendreau","year":"2011","unstructured":"Gendreau L, Loewy ZG: Epidemiology and etiology of denture stomatitis. J Prosthodont. 2011, 20: 251-260. 10.1111\/j.1532-849X.2011.00698.x.","journal-title":"J Prosthodont"},{"key":"475_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.archoralbio.2008.09.005","volume":"54","author":"C Marcos-Arias","year":"2009","unstructured":"Marcos-Arias C, Vicente JL, Sahand IH, Egu\u00eda A, De-Juan A, Madariaga L, Aguirre JM, Eraso E, Quind\u00f3s G: Isolation of Candida dubliniensis in denture stomatitis. Arch Oral Biol. 2009, 54: 127-131. 10.1016\/j.archoralbio.2008.09.005.","journal-title":"Arch Oral Biol"},{"key":"475_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1600-0757.2008.00291.x","volume":"49","author":"LP Samaranayake","year":"2009","unstructured":"Samaranayake LP, Leung WK, Jin L: Oral mucosal fungal infections. Periodontology 2000. 2009, 49: 39-59. 10.1111\/j.1600-0757.2008.00291.x.","journal-title":"Periodontology 2000"},{"key":"475_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1834-7819.1998.tb00152.x","volume":"43","author":"BC Webb","year":"1998","unstructured":"Webb BC, Thomas CJ, Willcox MD, Harty DW, Knox KW: Candida-associated denture stomatitis. Aetiology and management: a review. Part 1. Factors influencing distribution of Candida species in the oral cavity. Aust Dent J. 1998, 43: 45-50. 10.1111\/j.1834-7819.1998.tb00152.x.","journal-title":"Aust Dent J"},{"key":"475_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1834-7819.1998.tb00172.x","volume":"43","author":"BC Webb","year":"1998","unstructured":"Webb BC, Thomas CJ, Willcox MD, Harty DW, Knox KW: Candida-associated denture stomatitis. Aetiology and management: a review. Part 3. Treatment of oral candidosis. Aust Dent J. 1998, 43: 244-249. 10.1111\/j.1834-7819.1998.tb00172.x.","journal-title":"Aust Dent J"},{"key":"475_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/13693780802641920","volume":"47","author":"F Barchiesi","year":"2009","unstructured":"Barchiesi F, Silvestri C, Arzeni D, Ganzetti G, Castelletti S, Simonetti O, Cirioni O, Kamysz W, Kamysz E, Spreghini E, Abruzzetti A, Riva A, Offidani AM, Giacometti A, Scalise G: In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. Med Mycol. 2009, 47: 321-326. 10.1080\/13693780802641920.","journal-title":"Med Mycol"},{"key":"475_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/mmy.38.5.354.361","volume":"38","author":"KA Hammer","year":"2000","unstructured":"Hammer KA, Carson CF, Riley TV: Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans. Med Mycol. 2000, 38: 355-362.","journal-title":"Med Mycol"},{"key":"475_CR8","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.2174\/138955709789878150","volume":"9","author":"A Palmeira de Oliveira","year":"2009","unstructured":"Palmeira de Oliveira A, Salgueiro L, Palmeira de Oliveira R, Martinez de Oliveira J, Pina Vaz C, Queiroz JA, Rodrigues AG: Anti-Candida activity of essential oils. Mini-Reviews in Medicinal Chemistry. 2009, 9: 1292-1305. 10.2174\/138955709789878150.","journal-title":"Mini-Reviews in Medicinal Chemistry"},{"key":"475_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/med.20050","volume":"26","author":"A Pauli","year":"2006","unstructured":"Pauli A: Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med Res Rev. 2006, 26: 223-268. 10.1002\/med.20050.","journal-title":"Med Res Rev"},{"key":"475_CR10","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1128\/JCM.00213-06","volume":"44","author":"E Eraso","year":"2006","unstructured":"Eraso E, Moragues MD, Villar-Vidal M, Sahand IH, Gonz\u00e1lez-G\u00f3mez N, Pont\u00f3n J, Quind\u00f3s G: Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species. J Clin Microbiol. 2006, 44: 3340-3345. 10.1128\/JCM.00213-06.","journal-title":"J Clin Microbiol"},{"key":"475_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijantimicag.2008.01.028","volume":"31","author":"S Dalleau","year":"2008","unstructured":"Dalleau S, Cateau E, Berg\u00e8s T, Berjeaud JM, Imbert C: In vitro activity of terpenes against Candida biofilms. Int J Antimicrob Agents. 2008, 31: 572-576. 10.1016\/j.ijantimicag.2008.01.028.","journal-title":"Int J Antimicrob Agents"},{"key":"475_CR12","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2010","unstructured":"Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 2010, CLSI, Wayne, PA, USA, CLSI document M27-A3 and Supplement S3, 3","edition":"3"},{"key":"475_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0732-8893(02)00525-4","volume":"45","author":"E Cant\u00f3n","year":"2003","unstructured":"Cant\u00f3n E, Pem\u00e1n J, Viudes A, Quind\u00f3s G, Gobernado M, Espinel-Ingroff A: Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagn Microbiol Infect Dis. 2003, 45: 203-206. 10.1016\/S0732-8893(02)00525-4.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"475_CR14","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.fct.2007.09.106","volume":"46","author":"F Bakkali","year":"2008","unstructured":"Bakkali F, Averbeck S, Averbeck D, Idaomar M: Biological effects of essential oils-a review. Food Chem Toxicol. 2008, 46: 446-475. 10.1016\/j.fct.2007.09.106.","journal-title":"Food Chem Toxicol"},{"key":"475_CR15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ijantimicag.2007.12.013","volume":"31","author":"PC Braga","year":"2008","unstructured":"Braga PC, Culici M, Alfieri M, Dal Sasso M: Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int J Antimicrob Agents. 2008, 31: 472-477. 10.1016\/j.ijantimicag.2007.12.013.","journal-title":"Int J Antimicrob Agents"},{"key":"475_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11046-003-4790-5","volume":"159","author":"MP Tampieri","year":"2005","unstructured":"Tampieri MP, Galuppi R, Macchioni F, Carelle MS, Falcioni L, Cioni PL, Morelli I: The inhibition of Candida albicans by selected essential oils and their major components. Mycopathologia. 2005, 159: 339-345. 10.1007\/s11046-003-4790-5.","journal-title":"Mycopathologia"},{"key":"475_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1046\/j.1365-2672.2000.00943.x","volume":"88","author":"SD Cox","year":"2000","unstructured":"Cox SD, Mann CM, Markham JL, Bell HC, Gustafson JE, Warmington JR, Wyllie SG: The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol. 2000, 88: 170-175.","journal-title":"J Appl Microbiol"},{"key":"475_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10096-010-1050-8","volume":"30","author":"A Ahmad","year":"2011","unstructured":"Ahmad A, Khan A, Akhtar F, Yousuf S, Xess I, Khan LA, Manzoor N: Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur J Clin Microbiol Infect Dis. 2011, 30: 41-50. 10.1007\/s10096-010-1050-8.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"475_CR19","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1128\/EC.00219-06","volume":"5","author":"MA Alem","year":"2006","unstructured":"Alem MA, Oteef MD, Flowers TH, Douglas LJ: Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development. Eukaryot Cell. 2006, 5: 1770-1779. 10.1128\/EC.00219-06.","journal-title":"Eukaryot Cell"},{"key":"475_CR20","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.1128\/AEM.68.11.5459-5463.2002","volume":"68","author":"G Ramage","year":"2002","unstructured":"Ramage G, Saville SP, Wickes BL, L\u00f3pez-Ribot JL: Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol. 2002, 68: 5459-5463. 10.1128\/AEM.68.11.5459-5463.2002.","journal-title":"Appl Environ Microbiol"},{"key":"475_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11046-007-0097-2","volume":"163","author":"M He","year":"2007","unstructured":"He M, Du M, Fan M, Bian Z: In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia. 2007, 163: 137-143. 10.1007\/s11046-007-0097-2.","journal-title":"Mycopathologia"},{"key":"475_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1472-765X.2003.01375.x","volume":"37","author":"B Oliva","year":"2003","unstructured":"Oliva B, Piccirilli E, Ceddia T, Pontieri E, Aureli P, Ferrini AM: Antimycotic activity of Melaleuca alternifolia essential oil and its major components. Lett Appl Microbiol. 2003, 37: 185-187. 10.1046\/j.1472-765X.2003.01375.x.","journal-title":"Lett Appl Microbiol"},{"key":"475_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijantimicag.2007.11.008","volume":"31","author":"RS Traboulsi","year":"2008","unstructured":"Traboulsi RS, Mukherjee PK, Ghannouma MA: In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients. Int J Antimicrob Agents. 2008, 31: 272-276. 10.1016\/j.ijantimicag.2007.11.008.","journal-title":"Int J Antimicrob Agents"},{"key":"475_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/jac\/dkh436","volume":"54","author":"F Chami","year":"2004","unstructured":"Chami F, Chami N, Bennis S, Trouillas J, Remmal A: Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. J Antimicrob Chemother. 2004, 54: 909-914. 10.1093\/jac\/dkh436.","journal-title":"J Antimicrob Chemother"},{"key":"475_CR25","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1099\/jmm.0.020693-0","volume":"59","author":"A Ahmad","year":"2010","unstructured":"Ahmad A, Khan A, Khan LA, Manzoor N: In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. J Med Microbiol. 2010, 59: 1178-1184. 10.1099\/jmm.0.020693-0.","journal-title":"J Med Microbiol"},{"key":"475_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/10412905.2000.9712177","volume":"12","author":"SC Chao","year":"2000","unstructured":"Chao SC, Young DG, Oberg CJ: Screening for inhibitory activity of essential oils on selected bacteria, fungi and viruses. J Essential Oil Res. 2000, 12: 639-649.","journal-title":"J Essential Oil Res"},{"key":"475_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.7547\/87507315-88-10-489","volume":"88","author":"JM Concha","year":"1988","unstructured":"Concha JM, Moore LS, Holloway WJ: Antifungal activity of Melaleuca alternifolia (tea-tree) oil against various pathogenic organisms. J Am Podiatr Med Assoc. 1988, 88: 489-492.","journal-title":"J Am Podiatr Med Assoc"},{"key":"475_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1471-2334-6-158","volume":"6","author":"F Mondello","year":"2006","unstructured":"Mondello F, De Bernardis F, Girolamo A, Cassone A, Salvatore G: In vivo activity of terpinen-4-ol. The main bioactive component of Malaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species. BMC Infect Dis. 2006, 6: 158-10.1186\/1471-2334-6-158.","journal-title":"BMC Infect Dis"},{"key":"475_CR29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.fct.2005.09.001","volume":"44","author":"KA Hammer","year":"2006","unstructured":"Hammer KA, Carson CF, Riley TV, Nielsen J: A review of the toxicity of Melaleuca alternifolia (tea-tree oil). Food Chem Toxicol. 2006, 44: 616-625. 10.1016\/j.fct.2005.09.001.","journal-title":"Food Chem Toxicol"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-11-119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6882-11-119\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-11-119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-11-119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:05:22Z","timestamp":1630519522000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/1472-6882-11-119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,26]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1186\/1472-6882-11-119","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,26]]},"assertion":[{"value":"30 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"119"}}